1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Boxer Capital, LLC Buys Spark Therapeutics Inc, Immunomedics Inc, Amicus Therapeutics Inc, Sells Biogen Inc, uniQure NV, Allakos Inc

Investment company Boxer Capital, LLC (Current Portfolio) buys Spark Therapeutics Inc, Immunomedics Inc, Amicus Therapeutics Inc, argenx SE, DBV Technologies SA, sells Biogen Inc, uniQure NV, Allakos Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Boxer Capital, LLC. As of 2019Q2, Boxer Capital, LLC owns 32 stocks with a total value of $1.1 billion. These are the details of the buys and sells.

For the details of Boxer Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/boxer+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Boxer Capital, LLC
  1. Mirati Therapeutics Inc (MRTX) - 1,715,560 shares, 16.58% of the total portfolio.
  2. Odonate Therapeutics Inc (ODT) - 3,363,377 shares, 11.58% of the total portfolio. Shares added by 12.91%
  3. BeiGene Ltd (BGNE) - 900,000 shares, 10.47% of the total portfolio.
  4. Immunomedics Inc (IMMU) - 6,567,000 shares, 8.55% of the total portfolio. Shares added by 60.17%
  5. Spark Therapeutics Inc (ONCE) - 600,000 shares, 5.76% of the total portfolio. New Position
New Purchase: Spark Therapeutics Inc (ONCE)

Boxer Capital, LLC initiated holding in Spark Therapeutics Inc. The purchase prices were between $97.7 and $114.01, with an estimated average price of $107.99. The stock is now traded at around $101.00. The impact to a portfolio due to this purchase was 5.76%. The holding were 600,000 shares as of .

New Purchase: Amicus Therapeutics Inc (FOLD)

Boxer Capital, LLC initiated holding in Amicus Therapeutics Inc. The purchase prices were between $10.96 and $14.4, with an estimated average price of $12.68. The stock is now traded at around $10.25. The impact to a portfolio due to this purchase was 2.72%. The holding were 2,325,000 shares as of .

New Purchase: argenx SE (ARGX)

Boxer Capital, LLC initiated holding in argenx SE. The purchase prices were between $115 and $141.58, with an estimated average price of $126.95. The stock is now traded at around $137.04. The impact to a portfolio due to this purchase was 2.66%. The holding were 200,000 shares as of .

New Purchase: Mersana Therapeutics Inc (MRSN)

Boxer Capital, LLC initiated holding in Mersana Therapeutics Inc. The purchase prices were between $3.84 and $6.4, with an estimated average price of $4.71. The stock is now traded at around $2.73. The impact to a portfolio due to this purchase was 0.79%. The holding were 2,084,000 shares as of .

New Purchase: Akero Therapeutics Inc (AKRO)

Boxer Capital, LLC initiated holding in Akero Therapeutics Inc. The purchase prices were between $18.08 and $19.83, with an estimated average price of $18.95. The stock is now traded at around $28.56. The impact to a portfolio due to this purchase was 0.71%. The holding were 396,695 shares as of .

New Purchase: Kadmon Holdings Inc (KDMN)

Boxer Capital, LLC initiated holding in Kadmon Holdings Inc. The purchase prices were between $1.65 and $2.9, with an estimated average price of $2.23. The stock is now traded at around $2.63. The impact to a portfolio due to this purchase was 0.71%. The holding were 3,688,100 shares as of .

Added: Immunomedics Inc (IMMU)

Boxer Capital, LLC added to a holding in Immunomedics Inc by 60.17%. The purchase prices were between $11.98 and $18.86, with an estimated average price of $15.07. The stock is now traded at around $14.15. The impact to a portfolio due to this purchase was 3.21%. The holding were 6,567,000 shares as of .

Added: DBV Technologies SA (DBVT)

Boxer Capital, LLC added to a holding in DBV Technologies SA by 26.19%. The purchase prices were between $7.58 and $10, with an estimated average price of $8.94. The stock is now traded at around $9.32. The impact to a portfolio due to this purchase was 0.85%. The holding were 5,300,000 shares as of .

Added: The Medicines Co (MDCO)

Boxer Capital, LLC added to a holding in The Medicines Co by 25.00%. The purchase prices were between $27.53 and $37.25, with an estimated average price of $32.61. The stock is now traded at around $32.86. The impact to a portfolio due to this purchase was 0.51%. The holding were 750,000 shares as of .

Sold Out: Biogen Inc (BIIB)

Boxer Capital, LLC sold out a holding in Biogen Inc. The sale prices were between $219.29 and $241.72, with an estimated average price of $230.78.



Here is the complete portfolio of Boxer Capital, LLC. Also check out:

1. Boxer Capital, LLC's Undervalued Stocks
2. Boxer Capital, LLC's Top Growth Companies, and
3. Boxer Capital, LLC's High Yield stocks
4. Stocks that Boxer Capital, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK